Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00088790 · ClinicalTrials.gov registry record · Phase 1
AZD5438 in Patients With Advanced Solid Malignancies
A Phase 1 study, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00088790 is a Phase 1 study that has completed, run by AstraZeneca.
The verdict
NCT00088790, a Phase 1 study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
Purpose of this study is to assess the safety and tolerability of AZD5438 given orally to patients with advanced solid malignancies A review of the emerging clinical tolerability and exposure data from this study in conjunction with preclinical and the available clinical pharmacodynamic data relating to AZD5438, led to a decision by AstraZeneca that the development of AZD5438 as a potential anti-cancer agent would be discontinued.
Interventions
- DRUG AZD5438
Trial Details
| Field | Value |
|---|---|
| Start Date | 2004-07 |
| Est. Completion | 2005-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00088790
The ClinicalTrials.gov registry entry for NCT00088790 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AZD5438 is the first listed.
NCT00088790 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00088790 about?
NCT00088790 is a clinical study titled "AZD5438 in Patients With Advanced Solid Malignancies". Purpose of this study is to assess the safety and tolerability of AZD5438 given orally to patients with advanced solid malignancies A review of the emerging clinical tolerability and exposure data from this study in conjunction with preclinical and the available clinical pharmacodynamic data relatin...
What is the current status of trial NCT00088790?
This trial is currently completed. It is a Phase 1 study. The study started on 2004-07. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00088790?
The interventions under investigation include: AZD5438 (DRUG).
Who is sponsoring clinical trial NCT00088790?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.